NTRR Explores Developing All-Natural Alternative to Adderall

  NTRR Explores Developing All-Natural Alternative to Adderall

Business Wire

TAMPA, Fla. -- July 24, 2014

In its mission to deliver all-natural, cutting-edge wellness solutions, Neutra
Corp. (OTCBB: NTRR) is exploring the development of an herbal supplement
alternative to the drug Adderall.

Adderall is an effective and widely-prescribed drug used to treat narcolepsy
and ADHD. Like many prescription drugs, however, Adderall can be habit-forming
and produce undesirable side-effects such as high blood pressure, tremors,
hallucinations, nausea, sleep problems, anxiety and many more. By developing
an over-the-counter supplement using only all-natural ingredients, NTRR
believes it can provide a better solution.

“Our goal would be the development of a capsule that can provide many of the
benefits of Adderall without the dangerous side-effects and potential for
addiction,” said NTRR CEO Sydney Jim. “We’re currently seeking out potential
development partners who can help us produce a new nutraceutical that can
change the lives of people currently addressing various wellness issues with
Adderall and other expensive prescriptions.”

Neutra Corp. is dedicated to commercializing innovative, all-natural products
to compete in the fast-growing wellness sector alongside Herbalife Ltd.
(NYSE:HLF),Vitamin Shoppe (NYSE:VSI), Nutraceutical International Corp.
(NASDAQ:NUTR) andSchiff Nutrition International Inc. (NYSE:WNI).

About Neutra Corp.

Neutra Corp.is a healthy lifestyle company that specializes in the
development and marketing of natural wellnesssolutions, including
cannabis-related products and services as well as protective, anti-microbial
coatings for indoor and outdoor surfaces. For investing information and
performance data, please visitwww.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: This news release contains forward-looking information within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, including statements
that include the words "believes," "expects," "anticipate" or similar
expressions. Suchforward-looking statementsinvolve known and unknown risks,
uncertainties and other factors that may cause the actual results, performance
or achievements of the company to differ materially from those expressed or
implied by such forward-looking statements. In addition, description of
anyone's past success, either financial or strategic, is no guarantee of
future success. This news release speaks as of the date first set forth above
and the company assumes no responsibility to update the information included
herein for events occurring after the date hereof.

Contact:

Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
 
Press spacebar to pause and continue. Press esc to stop.